Journals / Retina-Vitreus / 2009 / Cilt: 17 - Sayı: 4

Yaşa bağlı makula dejenereransı ve santral kornea kalınlığı arasındaki ilişki

Association between central corneal thickness and Age-related macular degeneration

Pages
251–254
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: CCT do not seem to have an association with the development of neovascular or nonneovascular AMD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To determine any relationship between the development of age-related macular degeneration (AMD) and central corneal thickness (CCT).
📊
Key Findings & Data:Results: The mean age was 71.1 years in the AMD group, and 65.5 years in the control group.
💡
Conclusion & Impact:Conclusion: CCT do not seem to have an association with the development of neovascular or nonneovascular AMD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Yaşlı · Varyans analizi · Kornea

Abstract

Purpose: To determine any relationship between the development of age-related macular degeneration (AMD) and central corneal thickness (CCT). Material and Methods: The CCT of patients with neovascular or nonneovascular AMD and of healthy control subjects were measured by using ultrasound corneal pachymetry. ANOVA test was used to compare the CCT between the groups. Results: The mean age was 71.1 years in the AMD group, and 65.5 years in the control group. There were 100 eyes (100 patients,1 eye from each patient) in the AMD group and 116 eyes (116 patients,1 eye from each patient) in the control group. Half of the 100 eyes with AMD had neovascular AMD and the remaining had nonneovascular AMD. The mean CCT was 550.29±28.58 μ (462-620) in the AMD group as a total and 547.75±33.80 μ (485-650) in the control group (p>0.05). The CCT of neovascular AMD eyes was thinner (545.45±25,26 μ) (472-589) than that of both the control group (547.75±33.80 μ) and the nonneovascular AMD group (557.35±31.00 μ) (462-620), but the difference was not statistically significant. The difference between the neovascular and nonneovascular AMD groups was not statistically significant (545.45 vs. 557.35 μ, p=0.07). Conclusion: CCT do not seem to have an association with the development of neovascular or nonneovascular AMD.

Özet

Amaç: Yaşa bağlı makula dejeneresansı (YBMD) ile santral kornea kalınlığı (SKK) arasındaki muhtemel ilişkiyi değerlendirmek. Gereç ve Yöntem: YBMD tanısı almış hastalar ve yaşa göre eşleştirilmiş sağlıklı bireylerin ultrason pakimetri kullanılarak SKK ölçümü yapıldı. YBMD grubu sağlıklı grupla SKK’ları açısından ANOVA testi kullanılarak karşılaştırıldı. Bulgular: YBMD grubunda yaş ortalaması 71.1, kontrol grubunda 65.5 idi. YBMD grubunda 100 göz (100 hasta, herbir hastanın 1 gözü), kontrol grubunda 116 göz (116 hasta,herbir hastanın 1 gözü) çalışmaya dahil edildi. YBMD grubunda 100 gözün yarısında yaş tip diğer yarısında kuru tipte YBMD mevcuttu. Ortalama SKK YBMD grubunda 550.47±28.58 μ (462-620) iken normal grupta 547.75±33.80 μ (485-650) idi (p>0.05). SKK yaş tipte YBMD olan gözlerde (545.45±25.26 μ) (472-589) kontrol grubu (547.75±33.80 μ) ve kuru tipteki YBMD olan gözlere (557.35±31.00 μ) (462-620) kıyasla daha ince idi, fakat istatistiksel olarak anlamlı değildi (p>0.05). Yaş ve kuru tipte YBMD olan gözlerde iki grup arasındaki farkta istatistiksel olarak anlamlı değildi (545.45 vs. 557.35 μ, p=0.07).

🔖

Cite This Article

HÜSE, N., ÖZDEK, Ş., ERDİNÇ, A., HASANREİSOĞLU, B. (2009). Yaşa bağlı makula dejenereransı ve santral kornea kalınlığı arasındaki ilişki. Retina-Vitreus, Cilt: 17 - Sayı: 4, 251–254. https://ajindex.com/articles/307753

References (17)

  1. Klein R, Klein BEK, Jensen S, et al.: The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmolology. 1998;116:506-513
  2. Smith W, Assink J, Klein R, et al.: Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697-704
  3. Clemons TE, Milton RC, Klein R, et al.: Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS). AREDS report no
  4. Ophthalmology. 2005;112:533-539
  5. Jonas JB, Stroux A, Velten I, et al.: Central Corneal Thickness Correlated with Glaucoma Damage and Rate of Progression. Invest Ophthalmol Vis Sci. 2005;46:1269-1274
  6. Evereklioglu C, Er H.: Increased corneal thickness in active Behcet’s disease. Eur J Ophthalmol. 2002;12:24-29
  7. Evereklioglu C, Yılmaz K, Bekir NA.: Decreased central corneal thickness in children with Down syndrome. J Pediatr Ophthalmol Strabismus. 2002;39:274-277
  8. Sanchis-Gimeno JA, Lleo-Perez A, Alonso L, et al.: Reduced corneal thickness values in postmenopausal women with dry eye. Cornea. 2005;24:39-44
  9. Busten N, Olsen T, Schmitz O.: Clinical observations on the corneal thickness and the corneal endothelium in diabetes mellitus. Br J Ophthalmol. 1981;65: 687-690
  10. Pedersen U, Bramsen T.: Central corneal thickness in osteogenesis imperfecta and otosclerosis. ORL J Otorhinolaryngol Relat Spec. 1984;46:38-41
  11. Hansen FK, Ehlers N, Bentzen O, et al.: Central corneal thickness in retinal detachment. Acta Ophthalmol (Copenh). 1971;49:467- 472
  12. Ehlers N, Hjordal J.: Corneal thickness: measurement and implications. Exp Eye Res. 2004;78:543-548
  13. Copt RP, Thomas R, Mermoud A.: Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol. 1999;117:14-16
  14. Mitchell P, Smith W, Attebo K, et al.: Prevalance of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102:1450-1460
  15. VanNewkirk MR, Nanjan MB, Wang JJ, et al.: The prevalance age-related maculopathy: the visual impairment project. Ophthalmology. 2000;107:1593-1600
  16. Seddon JM, Rosner B, Sperduto RD, et al.: Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol. 2001;119:1191-1199
  17. Klein BE, Klein R, Lee KE.: Cardiovascular disease, selected cardiovascular disease risk factors, and age-related